Invention Grant
- Patent Title: Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
-
Application No.: US14758138Application Date: 2013-12-23
-
Publication No.: US09951038B2Publication Date: 2018-04-24
- Inventor: Dawit Tadesse
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Purdue Pharma L.P.
- Agent Alan L. Koller; Weiying Yang
- International Application: PCT/IB2013/002874 WO 20131223
- International Announcement: WO2014/102589 WO 20140703
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D451/14

Abstract:
The present disclosure relates to Quinazolin-4(3H)-one-Type Piperidine Compounds, such as those of Formule (I) and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, Q, Y1, Z, A, B, E, and a are as defined herein; compositions comprising an effective amount of a Quinazolin-4(3H)-one-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Quinazolin-4(3H)-one-Type Piperidine Compound.
Public/Granted literature
- US20160002203A1 QUINAZOLIN-4(3H)-ONE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF Public/Granted day:2016-01-07
Information query